Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Evgeniy V. Shlyakhto"'
Autor:
Sergey A. Maksimov, Svetlana A. Shalnova, Yuliya A. Balanova, Aleksandr D. Deyev, Svetlana E. Evstifeyeva, Asiya E. Imayeva, Anna V. Kapustina, Nataliya S. Karamnova, Galina A. Muromtseva, Oksana P. Rotar, Evgeniy V. Shlyakhto, Sergey A. Boytsov, Oksana M. Drapkina
Publikováno v:
Russian Open Medical Journal, Vol 9, Iss 2, p e0214 (2020)
Objective ― Analyzing gender-related specificities of hyperuricemia associations with lifestyle choices in the Russian Federation (RF) population. Material and Methods ― Cross-sectional survey was performed within the guidelines of the Russian na
Externí odkaz:
https://doaj.org/article/f6012a1dbaa9400794df95e14058dae8
Publikováno v:
Journal of Comparative Effectiveness Research. 8:113-120
Aim: To identify correlations between quality of life (QoL), emotional and mental state in patients with Type 2 diabetes mellitus (T2DM) and to evaluate its contribution in prediction of compliance. Materials & methods: The T2DM patients aged 18–75
Autor:
Svetlana E. Evstifeyeva, Sergey Boytsov, Svetlana A. Shalnova, G. A. Muromtseva, Aleksandr D. Deyev, A. V. Kapustina, Sergej A. Maksimov, Asiya E. Imayeva, O. M. Drapkina, Evgeniy V. Shlyakhto, Oksana P. Rotar, N.S. Karamnova, Yuliya Andreevna Balanova
Publikováno v:
Russian Open Medical Journal, Vol 9, Iss 2, p e0214 (2020)
Objective ― Analyzing gender-related specificities of hyperuricemia associations with lifestyle choices in the Russian Federation (RF) population. Material and Methods ― Cross-sectional survey was performed within the guidelines of the Russian na
Autor:
Dmitriy V. Zakharov, Irina V. Vakhrameyeva, Oleg G. Rudomanov, Evgeniy M. Nifontov, Vyachesla V. Kazarin, Vladimir V. A. Almazov, Natalya V. Vakhrameyeva, Evgeniy V. Shlyakhto
Publikováno v:
American Journal of Cardiovascular Drugs. 2:119-124
To evaluate the effects of add-on treatment with trimetazidine, single dose and long-term, on clinical and objective parameters of ischemia in patients with stable angina pectoris receiving standard antianginal therapy.One-month single-blind, placebo